Latest Brain natriuretic peptide Stories
DUBLIN, December 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/str4n4/global_cardiac) has announced the addition of the "Global
LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction.
- Statistically significant and durable reductions in troponin and NT-proBNP SAN DIEGO, Feb.
Among patients at risk of heart failure, collaborative care based on screening for certain levels of brain-type natriuretic peptide reduced the combined rates of left ventricular systolic dysfunction, diastolic dysfunction, and heart failure as well as emergency cardiovascular hospitalizations.
The novel angiotensin receptor neprilysin inhibitor, LCZ696, demonstrated beneficial effects in heart failure patients with preserved ejection fraction (HFpEF), according to results of the PARAMOUNT (Prospective compArison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion) trial.
- A hairdresser.